Cervello Therapeutics was created with an emphasis on finding a cure for a rare medical condition, Cerebral Cavernous Malformation (CCM). This privately-held company was established with a virtual drug discovery business paradigm, to capitalize on the global contract research organization resources, investing in companies that focus on specific research areas, rather than investing internally in expert staff across the wide range of functional areas needed for drug discovery.